Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 14)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A CXM: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Centrex Metals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Cardium Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CARDIUM THERA -- CXM 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ADLS , CXM , INHX , THLD -- DRUGS 3 $4 View Abstract
12-Jan-10 EconomicInvestor N/A "The Economy Matters" Report for CXM: the economy's impact on CXM's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct Cardium Therapeutics, Inc. Financial and Strategic Analysis Review 37 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
Next 4

Independent Reports (Showing 1 to 10 of 14)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A CXM: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Centrex Metals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
6-Feb-10 Reuters Investment Profile N/A Cardium Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CARDIUM THERA -- CXM 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ADLS , CXM , INHX , THLD -- DRUGS 3 $4 View Abstract
12-Jan-10 EconomicInvestor N/A "The Economy Matters" Report for CXM: the economy's impact on CXM's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct Cardium Therapeutics, Inc. Financial and Strategic Analysis Review 37 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.